Ravi Amaravadi

A Comprehensive Patient-Derived Xenograft Collection Representing the Heterogeneity of Melanoma.

Dennie T. Frederick, G. Caponigro, M. Herlyn, 2017, Cell reports.

A Comprehensive Patient-Derived Xenograft Collection Representing the Heterogeneity of Melanoma.

Yiling Lu, Lauren E Haydu, Gordon B Mills, 2017, Cell reports.

A Comprehensive Patient-Derived Xenograft Collection A Comprehensive Patient-Derived Xenograft Collection Representing the Heterogeneity of Melanoma. Representing the Heterogeneity of Melanoma.

Dennie T. Frederick, G. Caponigro, M. Herlyn, 2022 .

HRS mediates tumor immune evasion by regulating proteostasis-associated interferon pathway activation

M. Herlyn, Wei Zhang, Xiaowei Xu, 2023, Cell reports.

Genetic and Genomic Characterization of 462 Melanoma Patient-Genetic and Genomic Characterization of 462 Melanoma Patient-Derived Xenografts, Tumor Biopsies, and Cell Lines. Derived Xenografts, Tumor Biopsies, and Cell Lines.

Dennie T. Frederick, M. Herlyn, J. Wargo, 2022 .

Upregulation of exosome secretion from tumor-associated macrophages plays a key role in the suppression of anti-tumor immunity

M. Herlyn, Shujing Liu, G. Karakousis, 2023, Cell reports.

Combination anti-PD-1 and anti-CTLA-4 therapy generates waves of clonal responses that include progenitor-exhausted CD8+ T cells.

D. Oldridge, R. Herati, M. Farwell, 2024, Cancer cell.